Joseph S Zakrzewski's Net Worth
$47.4 Million
Who is Joseph S Zakrzewski?
Joseph S Zakrzewski has an estimated net worth of $47.4 Million. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., INSULET CORP, AMARIN CORP PLC\UK, SANGAMO THERAPEUTICS, INC, Cyteir Therapeutics, Inc., ACCELERON PHARMA INC, LIPOSCIENCE INC, and DOV PHARMACEUTICAL INC.
SEC CIK
Joseph S Zakrzewski's CIK is 0001331852
Past Insider Trading and Trends
2021 was Joseph S Zakrzewski's most active year for acquiring shares with 18 total transactions. Joseph S Zakrzewski's most active month to acquire stocks was the month of May. 2021 was Joseph S Zakrzewski's most active year for disposing of shares, totalling 18 transactions. Joseph S Zakrzewski's most active month to dispose stocks was the month of March. 2018 saw Joseph S Zakrzewski paying a total of $1,700,000.00 for 604,376 shares, this is the most they've acquired in one year. In 2020 Joseph S Zakrzewski cashed out on 718,750 shares for a total of $6,282,870.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $19.9775
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| -19.77% | -100.00K |
$19.11 | -$1,911,410.00 | 405.88K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
∞
| 98.2K |
—
|
—
| 98.2K |
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INSULET CORP (PODD) Snapshot price: $199.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.73% | 2.71K |
—
|
—
| 30.56K |
May 17
| |||
Form 4
|
—
|
0
|
$29.95 | -$1,353,005.79 | 27.85K |
Mar 2
| |||
Form 4
| +15.85% | 3.81K |
—
|
—
| 27.85K |
May 11
| |||
Form 4
| +20.20% | 4.04K |
—
|
—
| 24.04K |
May 13
| |||
Form 4
| +25.00% | 4K |
—
|
—
| 20K |
Jun 2
| |||
Form 4
| +33.33% | 4K |
—
|
—
| 16K |
Jun 3
| |||
Form 4
| +50.00% | 4K |
—
|
—
| 12K |
Jun 1
| |||
Form 4
| -38.46% | -5.00K |
$20.39 | -$101,935.30 | 8K |
Feb 16 - Feb 17
| |||
Form 4
| +44.44% | 4K |
—
|
—
| 13K |
May 12
| |||
Form 4
| +80.00% | 4K |
—
|
—
| 9K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
∞
| 5K |
$4.71 | $23,550.00 | 5K |
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMARIN CORP PLC\UK (AMRN) Snapshot price: $1.195
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.50% | 12K |
$3.25 | $38,999.00 | 196.55K |
Dec 14 - Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +118.28% | 100K |
$3.40 | $340,000.00 | 184.55K |
Oct 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
$12.17 | -$5,262,870.00 | 84.55K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$17.42 | -$1,683,380.00 | 84.55K |
Scheduled
|
Dec 16
| ||
Form 4
|
—
|
0
|
$16.41 | -$1,481,580.00 | 84.55K |
Scheduled
|
Jul 5
| ||
Form 4
|
—
|
0
|
$11.21 | -$1,562,090.00 | 84.55K |
Scheduled
|
Jun 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
$14.30 | -$2,022,125.00 | 84.55K |
Scheduled
|
Feb 22
| ||
Form 4
|
—
|
0
|
$10.19 | -$2,716,390.00 | 84.55K |
Scheduled
|
Jan 10
| ||
Form 4
| -62.60% | -141.50K |
$8.14 | -$5,645,121.00 | 84.55K |
Scheduled
|
Dec 28 - Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
$7.00 | -$3,599,333.58 | 226.05K |
Scheduled
|
Sep 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +28.97% | 50.78K |
$1.54 | $78,196.58 | 226.05K |
Nov 18
| |||
Form 4
| +23.48% | 33.33K |
—
|
—
| 175.27K |
Jul 26
| |||
Form 4
| +7.58% | 10K |
$1.35 | $13,500.00 | 141.94K |
Jun 25
| |||
Form 4
| +8.20% | 10K |
$1.35 | $13,500.00 | 131.94K |
Jun 21
| |||
Form 4
| +8.93% | 10K |
$1.35 | $13,500.00 | 121.94K |
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$6.96 | -$1,681,815.00 | 111.94K |
Scheduled
|
Oct 1
| ||
Form 4
| +42.41% | 33.33K |
$7.83 | -$1,944,692.46 | 111.94K |
Scheduled
|
Jul 26 - Jul 27
| ||
Form 4
|
—
|
0
|
$6.66 | -$1,592,715.00 | 78.6K |
Scheduled
|
May 29
| ||
Form 4
|
—
|
0
|
$6.47 | -$1,638,560.00 | 78.6K |
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +6.79% | 5K |
$1.35 | $6,750.00 | 78.6K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 4
| +7.29% | 5K |
$1.35 | $6,750.00 | 73.6K |
Aug 22
| |||
Form 4/A
| +7.86% | 5K |
$1.35 | $6,750.00 | 68.6K |
Jul 15
| |||
Form 4
| +7.86% | 5K |
$1.35 | $6,750.00 | 68.6K |
Jul 15
| |||
Form 4
|
—
|
0
|
$9.24 | -$3,913,210.00 | 63.6K |
Scheduled
|
Apr 18
| ||
Form 4
| +18.66% | 10K |
$1.35 | $13,500.00 | 63.6K |
Mar 9
| |||
Form 4
|
—
|
0
|
$4.76 | -$408,755.00 | 53.6K |
Feb 25
| |||
Form 4
|
—
|
0
|
$4.94 | -$719,060.00 | 53.6K |
Scheduled
|
Feb 22
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.5498
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.93% | 12.5K |
—
|
—
| 60.7K |
Feb 25
| |||
Form 4
| +20.50% | 8.2K |
—
|
—
| 48.2K |
Feb 25
| |||
Form 4/A
| +33.33% | 10K |
—
|
—
| 40K |
May 18
| |||
Form 4
| +8.33% | 2.5K |
—
|
—
| 32.5K |
May 18
| |||
Form 4
| +20.00% | 5K |
$4.99 | $24,950.00 | 30K |
Mar 17
| |||
Form 4
| +400.00% | 20K |
$6.15 | $123,000.00 | 25K |
Mar 12 - Mar 13
| |||
Form 4
| +100.00% | 2.5K |
—
|
—
| 5K |
Jun 10
| |||
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyteir Therapeutics, Inc. (CYT) Snapshot price: $3.16
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.63% | 14.15K |
$1.69 | $23,913.50 | 227.44K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +15.89% | 21.2K |
$1.30 | $27,562.60 | 154.62K |
Dec 7
| |||
Form 4
| +0.56% | 743 |
$1.61 | $1,196.23 | 133.42K |
May 12
| |||
Form 4
| +61.27% | 50.41K |
$1.89 | $95,077.34 | 132.67K |
May 10 - May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +1.36% | 1.1K |
$9.91 | $10,895.67 | 82.27K |
Dec 23 - Dec 28
| |||
Form 4
| +0.25% | 200 |
$9.88 | $1,976.00 | 81.17K |
Dec 17
| |||
Form 4
| +4.79% | 3.7K |
$10.77 | $39,844.00 | 80.97K |
Dec 15
| |||
Form 4
|
∞
| 58.67K |
—
|
—
| 58.67K |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||